Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 15, Pages 4487-4496Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm060363v
Keywords
-
Categories
Funding
- NIDDK NIH HHS [R01 DK059953-05, DK-59953, R01 DK059953, R01 DK050124-04, DK-50124] Funding Source: Medline
Ask authors/readers for more resources
The 3D NMR structures of six octapeptide agonist analogues of somatostatin (SRIF) in the free form are described. These analogues, with the basic sequence H-DPhe/Phe(2)-c[Cys(3)-Xxx(7)-DTrp(8)-Lys(9)-Thr(10)-Cys(14)]-Thr-NH2 (the numbering refers to the position in native SRIF), with Xxx(7) being Ala/Aph, exhibit potent and highly selective binding to human SRIF type 2 (sst(2)) receptors. The backbone of these sst(2)-selective analogues have the usual type-II', beta-turn reported in the literature for sst(2/3/5)-subtype-selective analogues. Correlating the biological results and NMR studies led to the identification of the side chains of DPhe(2), DTrp(8), and Lys(9) as the necessary components of the sst(2) pharmacophore. This is the first study to show that the aromatic ring at position 7 (Phe(7)) is not critical for sst(2) binding and that it plays an important role in sst(3) and sst(5) binding. This pharmacophore is, therefore, different from that proposed by others for sst(2/3/5) analogues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available